- Rank12
- Previous Rank13
- CEOLarry J. Merlo
- Address1 CVS Dr., Woonsocket, RI 02895
- Websiteinfo.cvscaremark.com
CVS got a 3% bump in sales last year, driven mostly by increased pharmacy services and retail pharmacy sales. The company is transforming itself into more of a health services provider in order to take advantage of the spike in the number of insured patients created by healthcare reform. Pharmacy services sales have already jumped more than 10% during the first three months this year. That could help offset what CVS expects to lose in cigarette sales when it stops selling all tobacco products in its stores this October, which the company expects will trim roughly $2 billion from its annual sales.
Looking for leads, investment insights, or competitive intelligence?Buy Now
Key Financials
| $ Millions | % change | |
|---|---|---|
| Revenues | 126,761 | 2.9 |
| Profits | 4592 | 18.4 |
| Total Assets | 71,526 | - |
| Total Shareholder Equity | 37,938 | - |
| Market Value (on March 31, 2014) | 88,516 | - |
Profit as a % of
| Sales | 3.6 |
| Assets | 6.4 |
| Stockholders' Equity | 12.1 |
Earnings Per Share
| Earnings Per Share ($) | 3.74 |
| EPS % Change (from 2012) | 23.4 |
| EPS % Change (5 year) | 11.4 |
| EPS % Change (10 year) | 13.8 |
Total Return to Investors
| Total Return to Investors | 50.3 |
| Total Return to Investors (5 year, annualized) | 21.6 |
| Total Return to Investors (10 year, annualized) | 15.9 |
